China pharma holdings, inc. (CPHI)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10
Revenue

10,923

12,330

13,212

15,570

20,351

22,133

32,806

54,507

81,166

74,388

Cost of revenue

9,441

10,355

10,743

12,352

15,778

17,215

23,405

38,660

52,178

44,105

Inventory obsolescence

-

-

-

-

3,108

2,250

9,881

1,769

0

-

Gross profit

1,482

1,974

2,468

3,218

1,464

-

-480

14,076

28,988

30,282

Operating expenses:
Selling expenses

2,352

3,216

3,460

4,036

4,294

3,346

3,284

3,535

3,439

2,542

General and administrative expenses

2,289

1,949

2,019

2,265

1,896

1,716

2,404

2,874

3,716

3,039

Research and development expenses

229

172

90

365

961

-

1,683

438

-

-

Bad debt expense

3

604

1,393

1,086

10,147

31,352

10,752

871

108

505

Impairment loss

17,015

6,479

14,183

-

-

-

-

-

-

-

Impairment loss

-

-

-

3,962

104

-

-

-

-

-

Impairment of intangible assets

-

-

-

-

-

0

-

-

-

-

Losses from natural disaster

-

-

-

-

-

2,276

-

-

-

-

Losses from natural disaster

-

-

-

-

-

-

0

-

-

-

Impairment of intangible assets

-

-

-

-

-

-

-

593

0

-

Total operating expenses

21,890

12,422

21,148

11,717

17,404

41,490

18,125

8,313

7,264

6,087

Subsidy income

-

-

-

343

1,640

65

0

-

-

-

Government subsidy income

-

-

-

-

-

-

-

141

301

469

Loss from operations

-20,407

-10,447

-18,680

-8,155

-14,299

-38,757

-18,606

5,905

22,025

24,664

Other income (expense):
Interest income

27

38

64

130

119

69

8

4

7

15

Interest expense

321

451

539

849

-1,165

785

-348

-308

-255

-168

Net other expense

-

-

-

-

-1,045

716

-340

-303

-

-

Derivative gain

-

-

-

-

-

-

-

-

934

1,588

Net other expense

-294

-412

-474

-718

-

-

-

-

686

-

Loss before income taxes

-20,702

-10,860

-19,154

-8,874

-15,345

-39,473

-18,946

5,601

22,711

1,436

Income tax expense;

-

-

-

-

60

-

-

-

-

-

Income before income taxes

-

-

-

-

-

-

-

-

-

26,100

Income tax expense

-

-109

122

308

-

-77

-1,061

-983

-3,442

-2,686

Net loss

-20,702

-10,750

-19,277

-9,182

-15,405

-39,550

-

-

-

23,414

Net loss

-

-

-

-

-

-

-20,008

4,617

19,269

-

Other comprehensive income - foreign currency translation adjustment

-259

-2,122

3,439

-4,549

-4,693

-653

4,435

1,274

-

-

Other comprehensive income - foreign currency translation adjustment

-

-

-

-

-

-

-

-

5,080

3,721

Comprehensive income (loss)

-20,961

-12,872

-15,837

-

-

-

-

-

24,349

27,135

Comprehensive loss

-

-

-

-13,732

-20,098

-40,204

-15,572

5,891

-

-

Loss per share:
Basic and diluted

-0.48

-0.25

-0.44

-0.21

-0.35

-

-

-

-

-

Weighted average shares outstanding

43,579

43,579

43,579

43,579

43,579

-

-

-

-

-

Basic

-

-

-

-

-

-0.91

-0.46

0.11

0.44

0.54

Diluted

-

-

-

-

-

-0.91

-0.46

0.11

0.44

0.54